Poolbeg Pharma Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10.06	12.17	16.19	20.95
Cash & Short-Term Investments	10.06	12.17	16.19	20.95
Cash Growth	-28.75%	-24.84%	-22.70%	-
Accounts Receivable	0.01	-	-	0.01
Other Receivables	0.3	0.66	0.08	0.05
Receivables	0.31	0.66	0.08	0.06
Prepaid Expenses	0.63	0.67	0.88	0.45
Total Current Assets	11	13.5	17.16	21.46
Other Intangible Assets	2.01	1.93	2.13	1.56
Total Assets	13.01	15.43	19.29	23.02
Accounts Payable	0.56	0.08	0.29	0.08
Accrued Expenses	-	0.9	0.67	0.36
Other Current Liabilities	-	0.01	0	0
Total Current Liabilities	0.56	0.99	0.97	0.44
Total Liabilities	0.56	0.99	0.97	0.44
Common Stock	0.1	0.1	0.1	0.1
Additional Paid-In Capital	23.1	23.1	23.1	23.1
Retained Earnings	-13.21	-10.95	-7.02	-2.34
Comprehensive Income & Other	2.46	2.2	2.15	1.72
Shareholders' Equity	12.45	14.44	18.32	22.58
Total Liabilities & Equity	13.01	15.43	19.29	23.02
Net Cash (Debt)	10.06	12.17	16.19	20.95
Net Cash Growth	-28.75%	-24.84%	-22.70%	-
Net Cash Per Share	0.02	0.02	0.03	0.07
Filing Date Shares Outstanding	500	500	500	500
Total Common Shares Outstanding	500	500	500	500
Working Capital	10.44	12.51	16.19	21.02
Book Value Per Share	0.02	0.03	0.04	0.05
Tangible Book Value	10.44	12.51	16.19	21.02
Tangible Book Value Per Share	0.02	0.03	0.03	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.